Article
Contributions of hyperactive mutations in Mpro from SARS-CoV-2 to drug resistance
medRxiv · 2023 · Flynn, J. M.; Zvornicanin, S. N.; Shaqra, A. M.; Kurt Yilmaz, N.; Moquin, S.; Dovala, D.; Schiffer, C. A.; Bolon, D.
Key facts
| Title | Contributions of hyperactive mutations in Mpro from SARS-CoV-2 to drug resistance |
|---|---|
| First author | Flynn, J. M.; Zvornicanin, S. N.; Shaqra, A. M.; Kurt Yilmaz, N.; Moquin, S.; Dovala, D.; Schiffer, C. A.; Bolon, D. |
| Journal | medRxiv |
| Published | Oct 2, 2023 |
| DOI | 10.1101/2023.09.28.560010 |
| Devices mentioned | K202641, K231013 |
| Product codes mentioned | PFF, PFT, QBD |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1